Department of Radiology

Publications

2019

Guo Y, Liu Z, Wen Y, Spincemaille P, Zhang H, Jafari R, et al. Quantitative susceptibility mapping of the spine using in-phase echoes to initialize inhomogeneous field and R2* for the nonconvex optimization problem of fat-water separation. NMR Biomed. 2019;32(11):e4156.

Amor-Coarasa A, Kelly JM, Babich JW. 3D-printed automation for optimized PET radiochemistry. Sci Adv. 2019;5(9):eaax4762.

S Bandt K, de Rochefort L, Chen W, Dimov AV, Spincemaille P, Kopell BH, et al. Clinical Integration of Quantitative Susceptibility Mapping Magnetic Resonance Imaging into Neurosurgical Practice. World Neurosurg. 2019;122:e10-e19.

Miyata M, Kakeda S, Kudo K, Iwata S, Tanaka Y, Wang Y, et al. Evaluation of oxygen extraction fraction in systemic lupus erythematosus patients using quantitative susceptibility mapping. J Cereb Blood Flow Metab. 2019;39(8):1648-1658.

Byron K, Winkler SA, Robb F, Vasanawala S, Pauly J, Scott G. An MRI Compatible RF MEMs Controlled Wireless Power Transfer System. IEEE Trans Microw Theory Tech. 2019;67(5):1717-1726.

Kaunzner UW, Kang Y, Zhang S, Morris E, Yao Y, Pandya S, et al. Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions. Brain. 2019;142(1):133-145.

Goudey B, Fung BJ, Schieber C, Faux NG. A blood-based signature of cerebrospinal fluid Aβ status. Sci Rep. 2019;9(1):4163.

Kobayashi M, Benakis C, Anderson C, Moore MJ, Poon C, Uekawa K, et al. AGO CLIP Reveals an Activated Network for Acute Regulation of Brain Glutamate Homeostasis in Ischemic Stroke. Cell Rep. 2019;28(4):979-991.e6.

Reisberg B, Torossian C, Shulman MB, Monteiro I, Boksay I, Golomb J, et al. Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment). J Alzheimers Dis. 2019;67(2):685-705.

Carrasquillo JA, Fine BM, Pandit-Taskar N, Larson SM, Fleming SE, Fox JJ, et al. Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using Zr-DFO-MSTP2109A Anti-STEAP1 Antibody. J Nucl Med. 2019;60(11):1517-1523.